Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jan;27(1):11-22.
doi: 10.1039/b920860g. Epub 2009 Oct 27.

Epigenome manipulation as a pathway to new natural product scaffolds and their congeners

Affiliations
Review

Epigenome manipulation as a pathway to new natural product scaffolds and their congeners

Robert H Cichewicz. Nat Prod Rep. 2010 Jan.

Abstract

The covalent modification of chromatin is an important control mechanism used by fungi to modulate the transcription of genes involved in secondary metabolite production. To date, both molecular-based and chemical approaches targeting histone and DNA posttranslational processes have shown great potential for rationally directing the activation and/or suppression of natural-product-encoding gene clusters. In this Highlight, the organization of the fungal epigenome is summarized and strategies for manipulating chromatin-related targets are presented. Applications of these techniques are illustrated using several recently published accounts in which chemical-epigenetic methods and mutant studies were successfully employed for the de novo or enhanced production of structurally diverse fungal natural products (e.g., anthraquinones, cladochromes, lunalides, mycotoxins, and nygerones).

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Outline illustrating the flow of genetic information leading to secondary metabolite biosynthesis in fungi and how these events are impacted by epigenetic processes.
Fig. 2
Fig. 2
Amino acid sequences of histone subunits H2A (A), H2B (B), H3 (C), and H4 (D) for the fungi (from top to bottom) Aspergillus niger, Coprinus cinereus, Phanerochaete chrysosporium, Aspergillus clavatus, Neosartorya fischeri, Fusarium graminearum, Magnaporthe grisea, Neurospora crassa, Saccharomyces cerevisiae, and Ustilago maydis. The sequences of human histones were included for comparisons to illustrate the substantial conservation of their primary structures. Pair-wise identities for the listed histone subunit sequences are 69%, 80%, 92%, and 94% for H2A, H2B, H3, and H4, respectively. Color-coding of the amino acid residues is as follows: bright green = identical residues; olive-green = highly conserved, but non-identical residues; orange = modest conservation of residues, and white = residue conservation is low or the residue is not present. Alignments were performed in Geneious v4.7 using sequence data available from GenBank and the Broad Institute Fungal Genome Initiative database.
Fig. 3
Fig. 3
Illustration showing the association of DNA with histones, as well as common posttranslational modifications that influence these interactions. Several epigenetic modifications that alter DNA and histones include (clockwise from the bottom left): methylation of histones and DNA, biotinylation, citrullination, ADP-ribosylation, phosphorylation, acetylation, glycosylation, ubiquitination, and sumoylation.
Fig. 4
Fig. 4
Acetylation of lysine residues found in histone tails and their interactions with DNA.
Fig. 5
Fig. 5
Example small-molecule inhibitors and their respective epigenetic targets.
Fig. 6
Fig. 6
Chromatograms of the reverse-phase-separated dichloromethane extracts of A. niger ATCC 1015 cultures treated with 7 showing the impact of HDAC inhibition on secondary metabolite diversity (UV traces at 210 nm were collected one and two weeks after addition of 10 μM of 7 or vehicle alone).

Similar articles

Cited by

References

    1. Galagan JE, Calvo SE, Cuomo C, Ma LJ, Wortman JR, Batzoglou S, Lee SI, Basturkmen M, Spevak CC, Clutterbuck J, Kapitonov V, Jurka J, Scazzocchio C, Farman M, Butler J, Purcell S, Harris S, Braus GH, Draht O, Busch S, D'Enfert C, Bouchier C, Goldman GH, Bell-Pedersen D, Griffiths-Jones S, Doonan JH, Yu J, Vienken K, Pain A, Freitag M, Selker EU, Archer DB, Penalva MA, Oakley BR, Momany M, Tanaka T, Kumagai T, Asai K, Machida M, Nierman WC, Denning DW, Caddick M, Hynes M, Paoletti M, Fischer R, Miller B, Dyer P, Sachs MS, Osmani SA, Birren BW. Nature. 2005;438:1105–1115. - PubMed
    1. Galagan JE, Calvo SE, Borkovich KA, Selker EU, Read ND, Jaffe D, FitzHugh W, Ma LJ, Smirnov S, Purcell S, Rehman B, Elkins T, Engels R, Wang S, Nielsen CB, Butler J, Endrizzi M, Qui D, Ianakiev P, Bell-Pedersen D, Nelson MA, Werner-Washburne M, Selitrennikoff CP, Kinsey JA, Braun EL, Zelter A, Schulte U, Kothe GO, Jedd G, Mewes W, Staben C, Marcotte E, Greenberg D, Roy A, Foley K, Naylor J, Stange-Thomann N, Barrett R, Gnerre S, Kamal M, Kamvysselis M, Mauceli E, Bielke C, Rudd S, Frishman D, Krystofova S, Rasmussen C, Metzenberg RL, Perkins DD, Kroken S, Cogoni C, Macino G, Catcheside D, Li W, Pratt RJ, Osmani SA, DeSouza CPC, Glass L, Orbach MJ, Berglund JA, Voelker R, Yarden O, Plamann M, Seiler S, Dunlap J, Radford A, Aramayo R, Natvig DO, Alex LA, Mannhaupt G, Ebbole DJ, Freitag M, Paulsen I, Sachs MS, Lander ES, Nusbaum C, Birren B. Nature. 2003;422:859–868. - PubMed
    1. Kroken S, Glass NL, Taylor JW, Yoder OC, Turgeon BG. Proc Natl Acad Sci U S A. 2003;100:15670–15675. - PMC - PubMed
    1. Fisch KM, Gillaspy AF, Gipson M, Henrikson JC, Hoover AR, Jackson L, Najar FZ, Wägele H, Cichewicz RH. J Ind Microbiol Biotechnol. 2009;36:1199–1213. - PubMed
    1. Corre C, Challis GL. Nat Prod Rep. 2009;26:977–986. - PubMed

Publication types

Substances